Analyst coverage

Firm	Analyst	Phone
Bank of America Merrill Lynch	Rachel McMinn	(415) 676-3519
Barclays Capital	Ying Huang	(212) 526-5387
BMO Capital Markets	Jim Birchenough, M.D.	(415) 591-2129
Brean Murray	Jonathan Aschoff	(212) 702-6652
Citibank	Jonathan Eckard	(212) 816-1441
Cowen & Co.	Phil Nadeau, Ph.D.	(646) 562-1336
Goldman, Sachs & Co.	Terence Flynn	(212) 357-5057
Guggenheim Partners	Brett Holley	(212) 293-2820
Jefferies & Co.	Eun Yang, Ph.D.	(212) 284-2264
JMP Securities	Michael G. King, Jr.	(212) 906-3520
JPMorgan Chase & Co.	Cory Kasimov	(212) 622-5266
Lazard Capital Markets, LLC	Ryan Martins	(415) 281-3446
Leerink Swann & Company	Howard Liang, Ph.D.	(617) 918-4857
Maxim Group	Echo He, M.D., Ph.D.	(212) 895-3718
Oppenheimer	David Ferreiro, Ph.D.	(212) 667-8163
RBC Capital Markets, LLC	Michael J. Yee	(415) 633-8522
Stifel Nicolaus	Joel Sendek	(212) 271-3867
Summer Street Research Partners	Carol Werther	(617) 532-6418
UBS	Matthew Harrison	(212) 713-2429
William Blair & Company, LLC	Y. Katherine Xu, Ph.D.	(212) 237-2758

ARIAD Pharmaceuticals, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding ARIAD Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ARIAD Pharmaceuticals, Inc. or its management. ARIAD Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.